Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Editorial [Hot topic: Cancer Therapy: Are we Missing the Target? (Guest Editor: Paola Gazzaniga)] promotion: free to download

Volume:10   Issue:5
Pp: 432-432
Paola Gazzaniga
DOI: 10.2174/156800910791517190

Past, Present and Future of Targeted Therapy in Solid Tumors

Volume:10   Issue:5
Pp: 433-461
A. Palazzo, R. Iacovelli and E. Cortesi
DOI: 10.2174/156800910791517145

Tyrosine Kinase Inhibitors

Volume:10   Issue:5
Pp: 462-483
C. Natoli, B. Perrucci, F. Perrotti, L. Falchi and S. Iacobelli
DOI: 10.2174/156800910791517208

The mTOR Pathway: A New Target in Cancer Therapy

Volume:10   Issue:5
Pp: 484-495
L. Ciuffreda, C. Di Sanza, U.C. Incani and M. Milella
DOI: 10.2174/156800910791517172

Cancer Stem Cells and Epithelial-Mesenchymal Transition: Revisiting Minimal Residual Disease

Volume:10   Issue:5
Pp: 496-508
C. Raimondi, W. Gianni, E. Cortesi and P. Gazzaniga
DOI: 10.2174/156800910791517154

Circulating Tumor Cells in Cancer Therapy: Are we off Target?

Volume:10   Issue:5
Pp: 509-518
C. Raimondi, G. Naso, A. Gradilone, W. Gianni, E. Cortesi and P. Gazzaniga
DOI: 10.2174/156800910791517163

Overcoming Endocrine Resistance in Breast Cancer

Volume:10   Issue:5
Pp: 519-528
R.A. Madaio, G. Spalletta, L. Cravello, M. Ceci, L. Repetto and G. Naso
DOI: 10.2174/156800910791517226

Clinical Advances in Hypomethylating Agents Targeting Epigenetic Pathways

Volume:10   Issue:5
Pp: 539-545
S. Cang, Q. Lu, Y. Ma and D. Liu
DOI: 10.2174/156800910791517217

Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo

Volume:10   Issue:5
Pp: 546-553
I. Ischenko, H. Seeliger, P. Camaj, A. Kleespies, M. Guba, M.E. Eichhorn, K.-W. Jauch and C.J. Bruns
DOI: 10.2174/156800910791517181